Therma Bright Submits AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Application for U.S. Food & Drug Administration’s Emergency Use Authorization (EUA)
Toronto, Ontario–(Newsfile Corp. – March 29, 2022) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF)…